Standardized Reporting for Systematic Global Evaluation of Axial Spondyloarthritis: An Evidence-Based and Consensus-Driven Initiative.

Spondyloarthritis comorbidities disease assessment e-health quality of life

Journal

Joint bone spine
ISSN: 1778-7254
Titre abrégé: Joint Bone Spine
Pays: France
ID NLM: 100938016

Informations de publication

Date de publication:
09 Apr 2024
Historique:
received: 03 01 2024
revised: 22 03 2024
accepted: 26 03 2024
medline: 12 4 2024
pubmed: 12 4 2024
entrez: 11 4 2024
Statut: aheadofprint

Résumé

National and international scientific societies advocate for a regular, systematic, and standardized global evaluation of axial spondyloarthritis (axSpA) patients. However, there are no recommendations specifying the content of this global evaluation. This initiative aimed to propose a standardized reporting framework, using evidence-based and consensus approaches, to collect data on all domains of axSpA. A literature review and consensus process involved a steering committee and an expert panel of 37 rheumatologists and health professionals. The first steering committee took place in March 2022 and identified the main domains for inclusion in the standardized report. A hierarchical literature review was conducted to identify items within these domains and tools for assessment. The items and tools for assessment were discussed and consensus was reached through a vote session during an expert meeting that took place in March 2023. The steering committee identified four main domains to include in the standardized reporting framework: disease assessment, comorbidities, lifestyle, and quality of life. Items and tools for assessment were adopted after the expert meeting. Additionally, recommendations regarding digital tools (websites, apps, social media) were provided. This initiative led to a consensus, based on evidence and expertise, on a reporting framework for use during periodic systematic global evaluations of axSpa in daily practice.

Identifiants

pubmed: 38604594
pii: S1297-319X(24)00044-7
doi: 10.1016/j.jbspin.2024.105733
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

105733

Informations de copyright

Copyright © 2024. Published by Elsevier Masson SAS.

Auteurs

Adeline Ruyssen-Witrand (A)

Rheumatology Centre, Toulouse University Hospital, Centre d'Investigation Clinique de Toulouse CIC1436, Inserm, Team PEPSS « Pharmacologie En Population cohorteS et biobanqueS ». University of Toulouse 3, Toulouse, France. Electronic address: ruyssen-witrand.a@chu-toulouse.fr.

Damien Caillet-Portillo (D)

Rheumatology Centre, Toulouse University Hospital, University of Toulouse 3, Toulouse, France.

Aurélie Najm (A)

Institute of Infection and Immunity, College of Medical Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom.

Olivier Fogel (O)

Department of Rheumatology, Hôpital Cochin. Assistance Publique - Hôpitaux de Paris, France.

Athan Baillet (A)

Univ. Grenoble-Alpes, TIMC - CNRS UMR5525, Grenoble, France.

Pascal Claudepierre (P)

APHP-Service de Rhumatologie, Hôpital Henri Mondor, AND Université Paris Est Créteil, EA 7379 - EpiDermE, France.

Orenella Conort (O)

Department Clinical Pharmacy, Hôpital Cochin. Assistance Publique - Hôpitaux de Paris, France.

Emmanuelle Dernis (E)

Department of Rheumatology and Clinical Immunology, General hospital Le Mans, France.

Françoise Fayet (F)

Rheumatology Centre, Clermont University Hospital, Clermont-Ferrand, France.

Laure Gossec (L)

Sorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique, Paris, AP-HP, Pitié-Salpêtrière hospital, Rheumatology department, Paris, France.

Philippe Goupille (P)

Université de Tours, EA 6295, Tours, Department of Rheumatology, University hospital of Tours, Tours, France.

Christophe Hudry (C)

Institut mutualiste Montsouris, Paris, France.

Jean-Guillaume Letarouilly (JG)

University of Lille, CHU Lille, FHU PRECISE, Rheumatology Department, Lille, France.

Cédric Lukas (C)

Department of Rheumatology, University Hospital Montpellier, Montpellier, INSERM UA11 (IDESP), University Montpellier, Montpellier, France.

Hubert Marotte (H)

Université Jean Monnet Saint-Étienne, CHU Saint-Étienne, Service de Rhumatologie, Mines Saint-Etienne, INSERM, SAINBIOSE U1059, 42023 Saint-Etienne, France.

Anna Molto (A)

ECAMO team (INSERM U1153), Center of Research in Epidemiology and Statistics (CRESS) - Université Paris Cité, paris, France.

Sophie Pouplin (S)

Rheumatology centre, Rouen University Hospital, Rouen, France.

Eric Senbel (E)

Centre de rhumatologie de l'Eldorado, Marseille, France.

Christelle Sordet (C)

Rheumatology Center, Strasbourg University Hospital, University of Strasbourg, Strasbourg, France.

Anne Tournadre (A)

Rheumatology Centre, Clermont University Hospital, UNH INRAe University Clermont Auvergne, Clermont-Ferrand, France.

Marie-Elise Truchetet (ME)

Department of Rheumatology, Hôpital Pellegrin, Bordeaux, France - Bordeaux University, CNRS, ImmunoConcept, UMR 5164, 33000 Bordeaux, France.

Daniel Wendling (D)

Rheumatology Centre, CHU de Besançon (University Hospital) and EA4266, Université de Franche-Comté, Besançon, France.

Maxime Dougados (M)

University of Paris-Cité, Department of Rheumatology, Hôpital Cochin. Assistance Publique - Hôpitaux de Paris -INSERM (U1153): Clinical epidemiology and biostatistics, PRES Sorbonne Paris-Cité, France. Electronic address: maxime.dougados@aphp.fr.

Classifications MeSH